Healthcare Opportunities 10-K 24 Jan 22 2020 FY Annual report Financial data

Cover

Cover - USD ($)	7 Months Ended
	Dec. 31, 2020	Jun. 30, 2020
Cover [Abstract]
Document Type	10-K
Amendment Flag	false
Document Annual Report	true
Document Transition Report	false
Document Period End Date	Dec. 31, 2020
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2020
Current Fiscal Year End Date	--12-31
Entity File Number	000-56188
Entity Registrant Name	EMERGING OPPORTUNITIES CORP
Entity Central Index Key	0001815547
Entity Tax Identification Number	85-1192377
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	c/o Franklin Ogele
Entity Address, Address Line Two	Esq
Entity Address, Address Line Three	One Gateway Center
Entity Address, Address Line Four	26th Fl
Entity Address, City or Town	Newark
Entity Address, State or Province	NJ
Entity Address, Postal Zip Code	07102
City Area Code	973
Local Phone Number	277 4239
Title of 12(g) Security	Common Stock, $0.0001 par value per share
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Elected Not To Use the Extended Transition Period	false
Entity Shell Company	false
Entity Public Float		$ 0
Entity Common Stock, Shares Outstanding	20,000,000

Balance Sheet

Balance Sheet	Dec. 31, 2020USD ($)
Current Asset
Cash and Cash Equivalents	$ 235
Total assets	235
Total assets	235
Liabilities:
Total liabilities	0
Owners’ Equity
Capital Stock	2,000
Additional Paid In Capital	4,000
Accumulated Deficit	(5,765)
Total owners’ equity	235
Total liabilities and owners’ equity	$ 235

Statements of Operations

Statements of Operations	7 Months Ended
	Dec. 31, 2020USD ($)
REVENUES
Service Revenue	$ 0
Total Revenues	0
Cost of revenue	0
Gross Profit	0
OPERATING EXPENSES
General & Administrative Expenses	765
Professional Fees	5,000
Total expenses	5,765
Net profit (loss) from operations	$ (5,765)

Statement of Changes in Owners'

Statement of Changes in Owners' Equity - 7 months ended Dec. 31, 2020 - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Beginning balance, value at May. 25, 2020
Owner contributions	2,000	4,000		6,000
Net income (loss)			(5,765)	(5,765)
Ending balance, value at Dec. 31, 2020	$ 2,000	$ 4,000	$ (5,765)	$ 235

Statements of Cash Flows

Statements of Cash Flows	7 Months Ended
	Dec. 31, 2020USD ($)
Cash flows from operating activities:
Change in net assets	$ (5,765)
(Increase) decrease in operating assets:
Operating assets	0
Increase (decrease) in operating liabilities:
Operating liabilities	0
Net cash provided by (used in) operating activities	(5,765)
Cash flows from investing activities:
Investing activities	0
Net cash provided by (used in) investing activities	0
Cash flows from financing activities:
Contribution of capital	6,000
Net cash provided by (used in) financing activities	6,000
Net increase (decrease) in cash	235
Cash:
Beginning of year	0
End of year	$ 235

Organization and Description of

Organization and Description of Business	7 Months Ended
	Dec. 31, 2020
Accounting Policies [Abstract]
Organization and Description of Business	Organization and Description of Business Emerging Opportunities Corp (the “Company”) was incorporated on May 26, 2020 under the laws of the The

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	7 Months Ended
	Dec. 31, 2020
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation These accompanying financial statements have been prepared in accordance with generally accepted Cash and Cash Equivalents The The following table depicts the composition of the Company’s cash and cash equivalents as of December Schedule of Cash and Cash Equivalents December 31, 2020 Deposits placed with banks $ 235.00 Total cash and cash equivalents $ 235.00 Concentration of Risk Financial instruments that potentially subject the Company to concentration of credit risk consist primarily Use of Estimates The preparation of consolidated financial statements in conformity with GAAP requires management to Fair Value of Financial Instruments The Company’s balance sheet includes financial assets which has been subject to valuation. The carrying ASC 820, Fair Value Measurements and Disclosures an entity’s own assumptions about market participant assumptions developed based on the ● Level ● Level ● Level Fair value estimates discussed herein are based upon certain market assumptions and pertinent Further Income Taxes The Company accounts for income taxes under ASC 740, Income Taxes Tax benefits related to uncertain tax positions are recognized when it is more likely than not that a tax Related Parties The Company follows ASC 850, Related Party Disclosures, The Revenue Recognition In May 2014, the FASB issued Accounting Standards Update No. 2014-09, Revenue from Contracts with Revenue Share-Based Compensation ASC 718, “ Compensation – Stock Compensation share-based payment transactions in which employee The Company accounts for Equity – Based Payments to Non- The Company did not have any stock-based compensation plans 0.00 Basic Earnings (Loss) Per Share The Earnings per Share The Company does not have any potentially dilutive instruments as of March 31, 2021 and, thus, anti- Recent Pronouncements The In August 2018, the FASB issued ASU 2018-14, regarding ASC Topic 820, Fair Value Measurement In May 2019, the FASB issued ASU 2019-05, regarding ASC 326, Financial Instruments – Credit Losses Financial

GOING CONCERN

GOING CONCERN	7 Months Ended
	Dec. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
GOING CONCERN	NOTE 3 – GOING CONCERN The accompanying financial statements have been prepared assuming the Company will continue as a As of December 31, 2020, the Company had a working capital of $ 235 5,765

INCOME TAXES

INCOME TAXES	7 Months Ended
	Dec. 31, 2020
Income Tax Disclosure [Abstract]
INCOME TAXES	NOTE 4 – INCOME TAXES Reconciliation of the income tax expense (benefit) computed at the U.S. Federal income tax rate to the Schedule of Effective Income Tax Rate Reconciliation For the period from inception to December 31, 2020 Profit / (loss) from operations before income tax $ (5,765 ) Income tax rate 21 % Income tax expense at the U.S Federal tax $ (1,211 ) Adjustments to derive effective tax rate: State and local net of federal benefit — Non-deductible stock bases compensation — Other non-deductible expenses — Non allowable carryover of losses 0 Valuation allowance $ 1,211 Income tax (benefit) / expenses $ — The ultimate realization of deferred tax assets depends primarily on the Company’s ability to generate The Schedule of Components of Deferred Income Tax December 31, 2020 Deferred tax assets: Net operating loss carryforwards 5,765 Less: valuation allowance (5,765 ) Total deferred tax asset $ — On December 22, 2017, the United States enacted the Tax Cuts and Jobs Act (“TCJA”), which instituted As of December 31, 2020, the Company had federal, state, and local net operating loss carryforwards of 5,765

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	7 Months Ended
	Dec. 31, 2020
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	NOTE 5 – RELATED PARTY TRANSACTIONS There no

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	7 Months Ended
	Dec. 31, 2020
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE 6 – COMMITMENTS AND CONTINGENCIES The Company estimates loss contingencies in accordance with FASB ASC 450-20, Loss Contingencies

STOCKHOLDERS_ DEFICIT

STOCKHOLDERS’ DEFICIT	7 Months Ended
	Dec. 31, 2020
Equity [Abstract]
STOCKHOLDERS’ DEFICIT	NOTE 7 – STOCKHOLDERS’ DEFICIT Common The authorized common stock of the Company consists of 20,000,000 0.0001 20,000,000 Pertinent Holders of shares of the Company’s common stock are entitled to one vote for each share held to be

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	7 Months Ended
	Dec. 31, 2020
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE SUBSEQUENT EVENTS In accordance with FASB ASC 855-10, Subsequent Events, the Company has analyzed its operations

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	7 Months Ended
	Dec. 31, 2020
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation These accompanying financial statements have been prepared in accordance with generally accepted
Cash and Cash Equivalents	Cash and Cash Equivalents The The following table depicts the composition of the Company’s cash and cash equivalents as of December Schedule of Cash and Cash Equivalents December 31, 2020 Deposits placed with banks $ 235.00 Total cash and cash equivalents $ 235.00
Concentration of Risk	Concentration of Risk Financial instruments that potentially subject the Company to concentration of credit risk consist primarily
Use of Estimates	Use of Estimates The preparation of consolidated financial statements in conformity with GAAP requires management to
Fair Value of Financial Instruments	Fair Value of Financial Instruments The Company’s balance sheet includes financial assets which has been subject to valuation. The carrying ASC 820, Fair Value Measurements and Disclosures an entity’s own assumptions about market participant assumptions developed based on the ● Level ● Level ● Level Fair value estimates discussed herein are based upon certain market assumptions and pertinent Further
Income Taxes	Income Taxes The Company accounts for income taxes under ASC 740, Income Taxes Tax benefits related to uncertain tax positions are recognized when it is more likely than not that a tax
Related Parties	Related Parties The Company follows ASC 850, Related Party Disclosures, The
Revenue Recognition	Revenue Recognition In May 2014, the FASB issued Accounting Standards Update No. 2014-09, Revenue from Contracts with Revenue
Share-Based Compensation	Share-Based Compensation ASC 718, “ Compensation – Stock Compensation share-based payment transactions in which employee The Company accounts for Equity – Based Payments to Non- The Company did not have any stock-based compensation plans 0.00
Basic Earnings (Loss) Per Share	Basic Earnings (Loss) Per Share The Earnings per Share The Company does not have any potentially dilutive instruments as of March 31, 2021 and, thus, anti-
Recent Pronouncements	Recent Pronouncements The In August 2018, the FASB issued ASU 2018-14, regarding ASC Topic 820, Fair Value Measurement In May 2019, the FASB issued ASU 2019-05, regarding ASC 326, Financial Instruments – Credit Losses Financial

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	7 Months Ended
	Dec. 31, 2020
Accounting Policies [Abstract]
Schedule of Cash and Cash Equivalents	Schedule of Cash and Cash Equivalents December 31, 2020 Deposits placed with banks $ 235.00 Total cash and cash equivalents $ 235.00

INCOME TAXES (Tables)

INCOME TAXES (Tables)	7 Months Ended
	Dec. 31, 2020
Income Tax Disclosure [Abstract]
Schedule of Effective Income Tax Rate Reconciliation	Schedule of Effective Income Tax Rate Reconciliation For the period from inception to December 31, 2020 Profit / (loss) from operations before income tax $ (5,765 ) Income tax rate 21 % Income tax expense at the U.S Federal tax $ (1,211 ) Adjustments to derive effective tax rate: State and local net of federal benefit — Non-deductible stock bases compensation — Other non-deductible expenses — Non allowable carryover of losses 0 Valuation allowance $ 1,211 Income tax (benefit) / expenses $ —
Schedule of Components of Deferred Income Tax	Schedule of Components of Deferred Income Tax December 31, 2020 Deferred tax assets: Net operating loss carryforwards 5,765 Less: valuation allowance (5,765 ) Total deferred tax asset $ —

SUMMARY OF SIGNIFICANT ACCOUN_4

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)	Dec. 31, 2020USD ($)
Accounting Policies [Abstract]
Deposits placed with banks	$ 235
Total cash and cash equivalents	$ 235

SUMMARY OF SIGNIFICANT ACCOUN_5

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)	10 Months Ended
	Mar. 31, 2021USD ($)
Accounting Policies [Abstract]
Stock-based compensation	$ 0

GOING CONCERN (Details Narrativ

GOING CONCERN (Details Narrative)	Dec. 31, 2020USD ($)
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Working capital	$ 235
Accumulated Deficit	$ 5,765

INCOME TAXES (Details)

INCOME TAXES (Details)	7 Months Ended
	Dec. 31, 2020USD ($)
Income Tax Disclosure [Abstract]
Profit (loss) from operations before income tax	$ (5,765)
Income tax rate	21.00%
Income tax expense at the U.S Federal tax	$ (1,211)
State and local net of federal benefit	0
Non-deductible stock bases compensation	0
Other non-deductible expenses	0
Non allowable carryover of losses	0
Valuation allowance	1,211
Income tax (benefit) / expenses	$ 0

INCOME TAXES (Details 1)

INCOME TAXES (Details 1)	Dec. 31, 2020USD ($)
Deferred tax assets:
Net operating loss carryforwards	$ 5,765
Less: valuation allowance	(5,765)
Total deferred tax asset	$ 0

INCOME TAXES (Details Narrative

INCOME TAXES (Details Narrative)	Dec. 31, 2020USD ($)
Income Tax Disclosure [Abstract]
Operating loss carryforwards	$ 5,765

RELATED PARTY TRANSACTIONS (Det

RELATED PARTY TRANSACTIONS (Details Narrative)	7 Months Ended
	Dec. 31, 2020USD ($)
Related Party Transactions [Abstract]
Related parties	$ 0

STOCKHOLDERS_ DEFICIT (Details

STOCKHOLDERS’ DEFICIT (Details Narrative)	Dec. 31, 2020$ / sharesshares
Equity [Abstract]
Common stock, shares authorized	20,000,000
Common stock, par value | $ / shares	$ 0.0001
Common stock, shares, issued	20,000,000